Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis

被引：0
|
作者：
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
机构：
[1] the Sino-US Center for Lymphoma and Leukemia Research,Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Researc
[2] The Ingenuity Centre,Systematic Review Solutions Ltd
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2817 / 2817
相关论文
共 50 条
  • [1] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
    Fenghua Gao
    Tingting Zhang
    Hengqi Liu
    Wei Li
    Xianming Liu
    Lihua Qiu
    Lanfang Li
    Shiyong Zhou
    Zhengzi Qian
    Sitong Dong
    Sai Zhao
    Xianhuo Wang
    Huilai Zhang
    Annals of Hematology, 2022, 101 : 2383 - 2392
  • [2] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis
    Gao, Fenghua
    Zhang, Tingting
    Liu, Hengqi
    Li, Wei
    Liu, Xianming
    Qiu, Lihua
    Li, Lanfang
    Zhou, Shiyong
    Qian, Zhengzi
    Dong, Sitong
    Zhao, Sai
    Wang, Xianhuo
    Zhang, Huilai
    ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2383 - 2392
  • [3] Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis (vol 101, pg 2383, 2022)
    Gao, Fenghua
    Zhang, Tingting
    Liu, Hengqi
    Li, Wei
    Liu, Xianming
    Qiu, Lihua
    Li, Lanfang
    Zhou, Shiyong
    Qian, Zhengzi
    Dong, Sitong
    Zhao, Sai
    Wang, Xianhuo
    Zhang, Huilai
    ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2817 - 2817
  • [4] Evaluation of the Different Stratification Models for POD24 Prediction in Patients with Follicular Lymphoma
    Wu, Wei
    Bruscaggin, Alessio
    Valera, Alexandra
    Flospergher, Elena
    Bonfiglio, Ferdinando
    Spina, Valeria
    Terzi-Di-Bergamo, Lodovico
    Moccia, Alden
    Moia, Riccardo
    Ruffini, Alessia
    Stathis, Anastasios
    Faderl, Martin
    Koch, Ricardo
    Forestieri, Gabriela
    Pini, Katia
    Condoluci, Adalgisa
    Pirosa, Maria Cristina
    Gerber, Bernhard
    Gillessen, Silke
    Stussi, Georg
    Ghielmini, Michele
    Cavalli, Franco
    Luminari, Stefano
    Boldorini, Renzo
    Mazzucchelli, Luca
    Gaidano, Gianluca
    Rossi, Davide
    Zucca, Emanuele
    BLOOD, 2020, 136
  • [5] REAL-LIFE IMPACT OF THE POD24 INDICATOR IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Noguerales Blanca, De Felipe
    de Abia Alejandro, Luna
    Arribas Ana, Lario
    Rumschisky Pablo, Palomo
    Jarreta Lucia, Bolea
    Palomares Juan, Marquet
    Moro Fernando, Martin
    Cosio Monica, Garcia
    Puente Pilar, Herrera
    Francisco Javier, Lopez Jimenez
    HAEMATOLOGICA, 2021, 106 (10) : 49 - 49
  • [6] Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma
    Zha, Jie
    Chen, Qinwei
    Zhang, Wei
    Jing, Hongmei
    Ye, Jingjing
    Yu, Haifeng
    Yi, Shuhua
    Li, Caixia
    Zheng, Zhong
    Xu, Wei
    Li, Zhifeng
    Ping, Lingyan
    He, Xiaohua
    Zhang, Liling
    Xie, Ying
    Chen, Feili
    Sun, Xiuhua
    Su, Liping
    Zhang, Huilai
    Lin, Zhijuan
    Yang, Haiyan
    Zhao, Weili
    Qiu, Lugui
    Li, Zhiming
    Song, Yuqin
    Xu, Bing
    BLOOD, 2023, 142
  • [7] A Systematic Literature Review and Meta-Analysis of Radioimmunotherapy Consolidation for Patients With Untreated Follicular Lymphoma
    Rose, Adam C.
    Shenoy, Pareen J.
    Garrett, Gia
    Seward, Miray
    Kucuk, Roy A.
    Doksansky, Hannah
    Nastoupil, Loretta J.
    Flowers, Christopher R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (06): : 393 - 399
  • [8] A Systematic Review and Meta-Analysis of Radioimmunotherapy Consolidation for Untreated Patients with Follicular Lymphoma (FL)
    Rose, Adam C.
    Garrett, Gia
    Seward, Miray
    Shenoy, Pareen T.
    Kucuk, Roy A.
    Doksansky, Hannah
    Flowers, Christopher R.
    BLOOD, 2011, 118 (21) : 49 - 49
  • [9] Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status
    Merryman, Reid W.
    Belada, David
    Sureda, Anna
    Leppa, Sirpa
    Vermaat, Joost S. P.
    Holte, Harald
    Hutchings, Martin
    Lugtenburg, Pieternella
    de Vos, Sven
    Abrisqueta, Pau
    Nijland, Marcel
    Christensen, Jacob Haaber
    Wahlin, Bjorn E.
    Linton, Kim M.
    Wang, Liwei
    Abbas, Aqeel
    Rana, Ali
    Quadri, Syed
    Falchi, Lorenzo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S454 - S454
  • [10] External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada
    Owen, Carolyn
    Chua, Neil
    Boyne, Devon
    Joe-Uzuegbu, Ofodile
    Shakir, Huma
    Gonga, Priyanka
    Brenner, Darren
    Elia-Pacitti, Julia
    Ewara, Emmanuel
    Cheung, Winson Y.
    BLOOD, 2022, 140 : 8024 - 8025
12345